Unstable angina / non ST elevation myocardial infarction and heart failure/cardiogenic shock
|
Unstable angina / NSTEMI Microchapters |
|
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
|
Special Groups |
|
Diagnosis |
|
Laboratory Findings |
|
Treatment |
|
Antitplatelet Therapy |
|
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
|
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
|
Mechanical Reperfusion |
|
Discharge Care |
|
Case Studies |
|
Unstable angina / non ST elevation myocardial infarction and heart failure/cardiogenic shock On the Web |
|
FDA on Unstable angina / non ST elevation myocardial infarction and heart failure/cardiogenic shock |
|
CDC onUnstable angina / non ST elevation myocardial infarction and heart failure/cardiogenic shock |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes (DO NOT EDIT) [1]
Recommendations for Heart Failure and Cardiogenic Shock
| Class I |
| "1.Patients with a history of HF and NSTE-ACS should be treated according to the same risk stratification guidelines and recommendations for patients without HF 15, (Level of Evidence: B)" |
| "2.Selection of a specific revascularization strategy should be based on the degree, severity, and extent of CAD; associated cardiac lesions; the extent of LV dysfunction; and the history of prior revascularization procedures (Level of Evidence: B)" |
| "3.Early revascularization is recommended in suitable patients with cardiogenic shock due to cardiac pump failure after NSTE-ACS (Level of Evidence: B)" |
- ↑ Ezra A. Amsterdam, MD, FACC; Nanette K. Wenger, MD et al.2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC. September 2014 (ahead of print)